-
Canagliflozin inhibits inflammasome activation in diabetic endothelial cells – Revealing a novel calcium-dependent anti-inflammatory effect of canagliflozin on human diabetic endothelial cells
Li, X., Kerindongo, R. P., Preckel, B., Kalina, J-O., Hollmann, M. W., Zuurbier, C. J. & Weber, N. C., 1 Mar 2023, In: Biomedicine and Pharmacotherapy. 159, 114228.Research output: Contribution to journal › Article › Academic › peer-review
-
Sodium glucose co-transporter 2 inhibitors ameliorate endothelium barrier dysfunction induced by cyclic stretch through inhibition of reactive oxygen species
Li, X., Römer, G., Kerindongo, R. P., Hermanides, J., Albrecht, M., Hollmann, M. W., Zuurbier, C. J., Preckel, B. & Weber, N. C., 1 Jun 2021, In: International journal of molecular sciences. 22, 11, 6044.Research output: Contribution to journal › Article › Academic › peer-review
-
Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor α-Stimulated Human Coronary Arterial Endothelial Cells
Uthman, L., Homayr, A., Juni, R. P., Spin, E. L., Kerindongo, R., Boomsma, M., Hollmann, M. W., Preckel, B., Koolwijk, P., van Hinsbergh, V. W. M., Zuurbier, C. J., Albrecht, M. & Weber, N. C., 2019, In: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology. 53, 5, p. 865-886Research output: Contribution to journal › Article › Academic › peer-review
- All publications
